Organon (OGN) Cash from Financing Activities (2020 - 2025)
Organon (OGN) has 6 years of Cash from Financing Activities data on record, last reported at -$187.0 million in Q4 2025.
- For Q4 2025, Cash from Financing Activities fell 128.05% year-over-year to -$187.0 million; the TTM value through Dec 2025 reached -$561.0 million, down 52.45%, while the annual FY2025 figure was -$561.0 million, 52.45% down from the prior year.
- Cash from Financing Activities reached -$187.0 million in Q4 2025 per OGN's latest filing, down from -$76.0 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $345.0 million in Q2 2021 and bottomed at -$1.1 billion in Q1 2021.
- Average Cash from Financing Activities over 5 years is -$145.4 million, with a median of -$82.0 million recorded in 2022.
- Peak YoY movement for Cash from Financing Activities: skyrocketed 150.29% in 2021, then crashed 327.78% in 2022.
- A 5-year view of Cash from Financing Activities shows it stood at -$187.0 million in 2021, then surged by 56.15% to -$82.0 million in 2022, then rose by 6.1% to -$77.0 million in 2023, then dropped by 6.49% to -$82.0 million in 2024, then crashed by 128.05% to -$187.0 million in 2025.
- Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$187.0 million in Q4 2025, -$76.0 million in Q3 2025, and -$223.0 million in Q2 2025.